Funder: PhRMA Foundation
Due Dates (Anticipated): April 2026 (Letter of Intent) | August 2026 (Full Application)
Funding Amounts: $60,000/year for up to 2 years; stipend only; renewal after 12 months contingent on progress report
Summary: Supports innovative, multidisciplinary postdoctoral research in drug discovery at accredited U.S. universities, with an emphasis on translational and early-stage projects.
Key Information: This is a forecasted opportunity; all dates are projected based on the annual cycle.